Response to influenza and pneumococcal vaccination in patients with multiple myeloma treated with lenalidomide with / without steroids and / or chemotherapy [Respons op influenza- en pneumokokkenvaccinatie bij patiënten met multipel myeloom die worden behandeld met lenalidomide met/zonder steroïden en/of chemotherapie]

Trial Profile

Response to influenza and pneumococcal vaccination in patients with multiple myeloma treated with lenalidomide with / without steroids and / or chemotherapy [Respons op influenza- en pneumokokkenvaccinatie bij patiënten met multipel myeloom die worden behandeld met lenalidomide met/zonder steroïden en/of chemotherapie]

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 29 Sep 2014

At a glance

  • Drugs Influenza virus vaccine (Primary) ; Pneumococcal 13-valent CRM197 vaccine conjugate (Primary)
  • Indications Influenza virus infections; Pneumococcal infections
  • Focus Therapeutic Use
  • Acronyms REVIVA
  • Most Recent Events

    • 29 Sep 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top